Mannitol Administration for Cerebellar Bleed in a 50kg Patient
For a 50kg patient with cerebellar hemorrhage and signs of increased intracranial pressure or brain herniation, administer mannitol 20% at a dose of 12.5-50 grams (0.25-1 g/kg) intravenously over 15-20 minutes, with the specific dose determined by clinical severity.
Dosing Algorithm
Initial dose calculation for 50kg patient:
- Acute intracranial hypertensive crisis: 0.5-1 g/kg = 25-50 grams over 15 minutes 1
- Standard elevated ICP: 0.25-0.5 g/kg = 12.5-25 grams over 20-30 minutes 2, 3
- Small/debilitated patients: 0.5 g/kg = 25 grams 4
The 2018 severe traumatic brain injury guidelines recommend 250 mOsm dose (approximately 0.5-1 g/kg) infused over 15-20 minutes for threatened intracranial hypertension or signs of brain herniation 1. This translates to 25-50 grams for your 50kg patient.
Administration Protocol
Preparation:
- Use 20% mannitol solution (200 mg/mL) 1
- Must use a filter when infusing 25% concentrations 4
- Warm crystallized solutions in hot water at 80°C before use 4
- Place urinary catheter before administration 2
Infusion specifics:
- Infuse over 15-20 minutes for acute herniation 1
- Infuse over 20-30 minutes for standard ICP elevation 2, 3
- Maximum effect occurs at 10-15 minutes, lasting 2-4 hours 1
Repeat Dosing Considerations
Maintenance dosing (if needed):
- 0.25-1 g/kg every 6 hours 5
- Maximum total dose: 2 g/kg 3
- Hold if serum osmolality ≥320 mOsm/kg 5
- Hold if osmolality gap ≥40 5
- Hold if sodium >155-160 mmol/L 5
Critical Monitoring Requirements
Before each dose, check:
- Serum osmolality (hold if ≥320 mOsm/kg)
- Electrolytes every 4-6 hours 5
- Renal function
- Fluid balance (mannitol causes osmotic diuresis requiring volume replacement) 1
Clinical monitoring:
- Level of consciousness
- Pupillary responses (watch for anisocoria, pinpoint pupils)
- Brainstem signs (bradycardia, irregular breathing) 6
- Blood pressure and cardiovascular status 4
Important Caveats for Cerebellar Hemorrhage
Cerebellar bleeds have unique considerations:
- Deterioration occurs from brainstem compression and obstructive hydrocephalus 6
- Watch for fourth ventricular compression
- Loss of oculocephalic responses indicates worsening 6
- Mannitol is a temporizing measure while arranging definitive treatment (surgical decompression/EVD) 3, 6
Contraindications to verify are absent:
- Well-established anuria/severe renal disease 4
- Severe pulmonary edema 4
- Active intracranial bleeding (except during craniotomy) 4
- Severe dehydration 4
Evidence Strength
The recommendation for mannitol at 250 mOsm dose over 15-20 minutes carries Grade 1+ evidence with strong agreement from the 2018 severe TBI guidelines 1. While this evidence derives from traumatic brain injury, it represents the highest quality guideline recommendation available and is referenced in stroke guidelines 3, 6. Mannitol was the only ICP-lowering therapy associated with improved cerebral oxygenation compared to hyperventilation and external ventricular drainage 1.
Hypertonic saline (3%) is an equally effective alternative at equiosmolar doses, though it causes hypernatremia/hyperchloremia rather than diuresis 1.
Adjunctive Measures
Combine mannitol with: